Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples